Mustang Financial Statements From 2010 to 2024

MBIO Stock  USD 0.19  0.01  5.00%   
Mustang Bio financial statements provide useful quarterly and yearly information to potential Mustang Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mustang Bio financial statements helps investors assess Mustang Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mustang Bio's valuation are summarized below:
Market Capitalization
8.9 M
Revenue
-50 K
Earnings Share
(1.33)
Revenue Per Share
(0)
We have found one hundred twenty available fundamental ratios for Mustang Bio, which can be analyzed and compared to other ratios and to its peers in the industry. Self-guided Investors are advised to check Mustang Bio's last-minute fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 3rd of December 2024, Market Cap is likely to drop to about 11 M. In addition to that, Enterprise Value is likely to drop to about 7.5 M
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Mustang Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Short and Long Term Debt Total2.4 M2.5 M7.3 M
Slightly volatile
Other Current Liabilities4.1 MM2.7 M
Slightly volatile
Total Current Liabilities9.2 M15.4 MM
Slightly volatile
Accounts PayableM6.3 M2.4 M
Slightly volatile
Common Stock Total Equity8.5 K8.1 K3.7 K
Slightly volatile
Common Stock Shares Outstanding5.3 M8.6 M6.9 M
Slightly volatile
Non Current Liabilities Total2.1 M2.2 M5.1 M
Pretty Stable
Capital Surpluse333.2 M317.4 M126.7 M
Slightly volatile
Other Stockholder Equity223.6 M381.1 M137 M
Slightly volatile
Total Liabilities15.5 M17.6 M10.9 M
Slightly volatile
Short and Long Term Debt1.4 M1.1 M2.1 M
Slightly volatile
Short Term DebtMM2.1 M
Slightly volatile
Common Stock95010003.1 K
Slightly volatile
Total Assets16.9 M17.7 M49 M
Slightly volatile
Cash5.9 M6.2 M40 M
Pretty Stable
Cash And Short Term Investments5.9 M6.2 M42.9 M
Slightly volatile
Liabilities And Stockholders Equity16.9 M17.7 M49 M
Slightly volatile
Total Current Assets10.8 M11.3 M44.3 M
Slightly volatile
Other Liabilities366 K310.5 K193.2 K
Slightly volatile
Property Plant And Equipment Net8.8 M4.8 M4.9 M
Slightly volatile
Net Receivables4.1 M3.9 M614.7 K
Slightly volatile
Other Current Assets1.7 M1.2 M986.5 K
Slightly volatile
Net Invested Capital116.8 K123 K57.7 M
Pretty Stable
Property Plant And Equipment Gross9.5 M9.3 M5.3 M
Slightly volatile
Capital Stock9501000K
Slightly volatile
Non Current Liabilities Other1.7 M2.2 M1.2 M
Slightly volatile
Long Term Debt Total9.7 M11 M11.9 M
Slightly volatile
Capital Lease Obligations2.8 M2.5 M2.3 M
Slightly volatile

Mustang Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General AdministrativeM9.7 M5.6 M
Slightly volatile
Research Development36.8 M39.2 M24.1 M
Slightly volatile
Total Operating Expenses45.5 M48.5 M29.6 M
Slightly volatile
Interest Income710.6 K1.1 M398.3 K
Slightly volatile
Other Operating Expenses50.8 M50.7 M32.6 M
Slightly volatile
Non Recurring8.4 M11.6 M7.7 M
Slightly volatile
Reconciled Depreciation1.9 M2.7 M912.6 K
Slightly volatile
Selling And Marketing Expenses292 K328.5 K357.7 K
Slightly volatile

Mustang Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock789.2 K830.7 K22.6 M
Slightly volatile
Depreciation1.4 M2.2 M849.9 K
Slightly volatile
Capital Expenditures108.3 K114 KM
Slightly volatile
Change To Netincome9.7 M12.7 M7.3 M
Slightly volatile
Other Non Cash Items2.2 M2.3 M7.5 M
Slightly volatile
Cash Flows Other Operating10.4 M18.2 M9.9 M
Slightly volatile
End Period Cash Flow6.6 MM40.5 M
Slightly volatile
Stock Based Compensation539.6 K568 K2.2 M
Very volatile
Begin Period Cash Flow67.3 M76.7 M45.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.04870.0512748
Slightly volatile
Payables Turnover0.360.35190.2338
Slightly volatile
Cash Per Share0.690.724516.6529
Pretty Stable
Days Payables Outstanding582K582
Slightly volatile
Income Quality0.50.95880.5287
Slightly volatile
Current Ratio0.70.73817.9022
Slightly volatile
Graham Number1.321.388950.553
Very volatile
Capex Per Share0.01260.01321.4604
Slightly volatile
Interest Debt Per Share0.20.21323.1451
Slightly volatile
Debt To Assets0.02780.02930.0671
Slightly volatile
Days Of Payables Outstanding582K582
Slightly volatile
Company Equity Multiplier15114420.7679
Slightly volatile
Long Term Debt To Capitalization0.220.330.2383
Slightly volatile
Quick Ratio0.70.73817.9022
Slightly volatile
Net Income Per E B T1.111.171.0453
Slightly volatile
Cash Ratio0.390.40567.0975
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.251.00231.1847
Slightly volatile
Debt Ratio0.02780.02930.0671
Slightly volatile

Mustang Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap11 M11.6 M207.3 M
Slightly volatile

Mustang Fundamental Market Drivers

Cash And Short Term Investments6.2 M

Mustang Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Mustang Bio Financial Statements

Mustang Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Mustang Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue310.5 K326 K
Cost Of Revenue2.2 M1.3 M

Pair Trading with Mustang Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Mustang Stock

  0.61EQ EquilliumPairCorr
  0.65VALN Valneva SE ADRPairCorr

Moving against Mustang Stock

  0.58VCYT VeracytePairCorr
  0.45VERA Vera TherapeuticsPairCorr
  0.44DRTS Alpha Tau Medical TrendingPairCorr
  0.42DMAC DiaMedica Therapeutics Downward RallyPairCorr
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.33)
Revenue Per Share
(0)
Return On Assets
(0.97)
Return On Equity
(11.91)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.